Transgenomic's Q1 Revenues Increase 8 Percent

The firm's instrument revenues grew 12 percent year over year, and it launched its KRAS test kit in Europe.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories